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The repertoire of lymphocyte receptors in the adaptive immune system protects organisms from
diverse pathogens. A well-adapted repertoire should be tuned to the pathogenic environment to
reduce the cost of infections. We develop a general framework for predicting the optimal repertoire
that minimizes the cost of infections contracted from a given distribution of pathogens. The theory
predicts that the immune system will have more receptors for rare antigens than expected from
the frequency of encounters; individuals exposed to the same infections will have sparse repertoires
that are largely different, but nevertheless exploit cross-reactivity to provide the same coverage of
antigens; and the optimal repertoires can be reached via the dynamics of competitive binding of
antigens by receptors, and selective amplification of stimulated receptors. Our results follow from
a tension between the statistics of pathogen detection, which favor a broader receptor distribution,
and the effects of cross-reactivity, which tend to concentrate the optimal repertoire onto a few highly
abundant clones. Our predictions can be tested in high throughput surveys of receptor and pathogen
diversity.
The adaptive immune system protects organisms from
a great variety of pathogens by maintaining a popula-
tion of specialized cells, each specific to particular chal-
lenges. Together these cells cover the array of potential
threats. To recognize pathogens, the immune system re-
lies on receptor proteins expressed on the surface of its
main constituents, the B and T lymphocytes. These re-
ceptors interact with antigens (small molecular elements
making up pathogens), recognize them through specific
binding, and initiate the immune response. Each lym-
phocyte expresses a unique receptor formed from random
combinations encoded in the genome. The receptors later
undergo selection through the death and division of the
lymphocytes that express them, as well as mutations in
the case of B lymphocytes. The diversity of the recep-
tor repertoire determines the range of threats that the
adaptive immune system can target.
The detailed composition of the immune receptor
repertoire, and not just its breadth, is important for con-
ferring effective protection against infections. Broadly
speaking, a diverse population of receptors will confer
wider immunity, and a larger clonal population of a
particular receptor will confer more effective immunity
against the pathogens to which it is specific. However,
there is a tradeoff between diversity and clone sizes be-
cause the number of receptors is limited. By selectively
proliferating some receptors at the expense of others,
the immune system retains a memory of past infections
[1], facilitating subsequent immune responses. Further-
more, while infections increase the populations of recep-
tors with the greatest specificity, they can also lead to a
reorganization of the immune repertoire as a whole [2].
How should the repertoire be organized to minimize
the cost of infections? We develop a framework for an-
swering this question by abstracting key general features
of the immune system: the receptor repertoire is bounded
in size, receptors are “cross-reactive” (each antigen binds
many receptors; each receptor binds many antigens), and
the cost of an infection increases with time. Given these
general assumptions, we consider a simplified landscape
of pathogens, where infections are drawn from a fixed
distribution. By simplifying the setting in this way, and
independently of the detailed dynamics of immune re-
sponses, we arrive at broad insights about the compo-
sition of immune repertoires that are optimal for their
pathogenic environments.
The theory predicts, counter-intuitively, that the num-
ber of receptors specific to rare pathogens will be ampli-
fied relative to the probability of encounter, at the ex-
pense of receptors for common infections. We also find
that two organisms responding to a pathogen distribu-
tion will display unique populations of immune receptors,
even though their coverage of pathogens will be simi-
lar. How can the immune system achieve these sorts of
optima? Surprisingly, we find that simple competition
between receptor clones can drive the population to the
optimal composition for minimizing the cost of infections.
New high throughput methods are making it possible
to survey B-cell and T-cell receptor diversity in fish [3, 4],
in mice [2, 5] and humans [6–9]. As methods are devel-
oped to better characterize pathogenic landscapes and
receptor cross-reactivity, predictions for the composition
of optimal repertoires derived from our framework can be
directly compared with experiments. To arrive at our re-
sults we ask how the immune system should be organized
to perform its function well, rather than starting with the
detailed dynamics of its components. We are proposing
that the universal features of the adaptive immune sys-
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2tem follow simply from general statistical considerations,
while the detailed dynamical implementation arises from
the historical contingencies of evolution.
I. DEFINITION OF THE PROBLEM
To find the optimal repertoire distribution we must
consider the nature of antigen-receptor interactions, and
a penalty that the immune system pays for not recog-
nizing antigens. This penalty must reflect the facts that
recognition should happen within reasonable time, before
the pathogen colony can significantly increase its size; the
interactions between the immune receptors and antigen
are probabilistic; and not all antigens are equally fre-
quent. We assume that, although the immune system
cannot predict precisely which antigens it will encounter
and when, it incorporates an estimate of the probabilities
of their occurrences. We also take these probabilities to
be constant in time. This is an idealization grounded in a
separation of timescales, which assumes the distribution
of antigens remains constant on timescales on which the
immune system adapts.
We call Qa the probability that the next infection will
be caused by antigen a (Fig. 1) and model the immune
repertoire by a distribution of receptors Pr, from which
lymphocytes with the corresponding receptor are drawn
at random. During its time in the periphery, an anti-
gen a will encounter and possibly interact with recep-
tors at a rate λa(t) which increases with time as the
pathogen population grows. Each encounter will occur
with a different receptor r drawn from Pr. The mean
number of encounters between antigens and receptors af-
ter a time t, which we will call effective time, is defined
as ma(t) =
∫ t
0
dτλa(τ), where t = 0 is set by the in-
troduction of the antigen. We shall see that the cost
of an infection is most easily expressed in terms of the
expected number of encounters before recognition, and
hence in terms of ma(t).
An antigen a and a receptor r interact with a cer-
tain strength set by the binding affinity between the two
molecules. This is described by the probability fr,a that
an antigen a colliding with the receptor r results in a
recognition event, leading to the activation of the lym-
phocyte expressing that receptor. fr,a will be called the
cross-reactivity function. Each encounter with a ran-
dom antigen has a probability P˜a =
∑
r fr,aPr to lead
to recognition and trigger an immune response. Since
recognition is a stochastic event, the time t to the first
recognition event, or response time, is random and dis-
tributed according to the probability distribution func-
tion Ha(t) = λa(t)P˜ae
−ma(t)P˜a (see App. A for a deriva-
tion).
The longer the system fails to detect the antigen, the
more likely the infection is to become harmful. We as-
sume that the integrated harm caused by an antigen since
the beginning of an infection is an increasing function
Fa(t) of the time of first recognition. The mean harm
✔  fr,a
λa(t)
ar
Qa
antigens
Pr
receptors
FIG. 1: Schematic of a statistical model of antigen recogni-
tion by the adaptive immune system. After infection, anti-
gen a encounters immune receptor r at random with a rate
λa(t). An encounter leads to a successful recognition with a
probability fr,a that reflects the matching between a given
antigen–receptor pair.
inflicted to the organism by the attack of an antigen a is
then given by this quantity averaged over the distribution
of possible response times: F¯a =
∫ +∞
0
dt Fa(t)Ha(t) =
P˜a
∫ +∞
0
dmFa[ta(m)] e
−mP˜a , where ta(m), the inverse
function of ma(t), is the amount of time it takes for m
encounters to occur between the immune receptors and
pathogen a. The result depends on the cost expressed as
a function of the effective time m, Fa[ta(m)], which we
denote Fa(m) to simplify notations.
We will consider several specific choices of the effec-
tive cost function in Results. Since not all antigens are
equally likely, the overall expected cost is this harm av-
eraged over the antigen distribution:
Cost({Pr}) = 〈F 〉 =
∑
a
QaF¯a. (1)
The need to defend against many antigens at the same
time with a limited number of receptors introduces a
trade-off. If more receptors recognize an antigen, there
are less to protect against other threats.
Our aim here is to propose a general framework for
thinking about the repertoire. Thus, we do not explic-
itly model intracellular communication, cell differentia-
tion, activation of co-factors, coordination of different cell
types, avoidance of self-antigens through thymic selec-
tion, and the full complexity of the recognition process.
The idea is that Fa(m) implicitly summarizes all of these
factors in terms of an effective cost. Of course, more de-
tailed modeling of the cost will be possible as we refine
our knowledge of the recognition process.
In general the cost function Fa(m) depends on the
antigen a, reflecting the various virulences of different
pathogens. To simplify, we can assume that the cost func-
tion takes the factorized form: Fa(m) = µaF (m), where
µa is the pathogen-dependent virulence factor, and F (m)
describes how all threats develop with time. The cost
will then take the form:
∑
a µaQaP˜a
∫∞
0
dmF (m)e−mP˜a .
In this expression, the virulence factor µa of a pathogen
plays the same role as its likelihood Qa. Some pathogens
are rare but very virulent (like anthrax), while others
may be common but not very virulent (like the common
cold), and an ideal immune system should be able to cope
3with both. In our model the overall “dangerousness” of
a pathogen is expressed as the product of the two, µaQa.
Therefore, for all practical purposes µa can be absorbed
into the definition of Qa, and will be omitted in the rest
of the paper.
Given such a model of the recognition process, there
exists an optimal adaptive immune system, character-
ized by the choice of the receptor distribution Pr, that
minimizes the expected cost in a given antigenic environ-
ment Qa. The optimal repertoire is found by minimizing
the expected cost in Eq. 1 with respect to Pr, subject to
constraints of non-negativity (Pr ≥ 0) and normalization
(
∑
r Pr = 1). Simple local extremality conditions are suf-
ficient for optimality because our problem can be shown
to be convex (see App. B). The condition
∑
r Pr = 1
is a normalized version of the constraint that the total
number of receptors is limited.
II. RESULTS
A. The optimal repertoire is more uniform than
the pathogen distribution
We can now ask how best to distribute the receptors to
minimize the cost (Eq. 1) for a given antigenic environ-
ment. To begin, we neglect cross-reactivity (later we will
see that this is equivalent to looking at the structure of
the repertoire at scales larger than the cross-reactivity).
In this case antigens and receptors can be associated one
by one by a cross-reactivity function fr,a = 1 if r = a and
0 otherwise. In this case we can analytically determine
the optimal distribution (App. D 2):
P ∗r = max
[
F¯ ′(−1)
(
− λ
Qr
)
, 0
]
, (2)
where F¯ ′(−1) denotes the inverse function of the deriva-
tive of F¯a = F¯ (P˜a) expressed as a function of P˜a,
and λ is a positive constant fixed by the normalization∑
r P
∗
r = 1. Table I presents results for several represen-
tative cost functions.
A simple scenario occurs when the pathogen popu-
lation grows exponentially in time, as do the cost and
the encounter rate—reflecting the proliferative nature of
pathogens. In this case the cost grows linearly in the
number of encounters, i.e. F (m) = m (see App. C). Then
we find that the optimal fraction of the repertoire taken
up by a given receptor is proportional to the square root
of the frequency of the corresponding antigen P ∗r ∝
√
Qr.
Intuitively, we expect that the optimal repertoire should
focus its resources on receptors recognizing the most com-
mon antigens. However this enhanced protection against
frequent antigens comes at the cost of a slower response
against the uncommon antigens, and this bias towards
common antigens must remain limited. The square root
dependence reflects a particular trade-off between these
two opposing constraints, by directing more resources to-
wards common antigens while uniformizing the distribu-
tion compared to a linear dependence. Intriguingly, the
same square root dependence has been found as an op-
timal solution for the size of tRNA pools as a function
of codon usage [10], and in a model for the screening of
suspicious individuals [11].
The extent to which more resources are directed to-
wards common antigens depends on the relative gains
and losses of earlier and later recognition events, which
are captured in our model by the effective cost function
F (m). In general, steeper cost functions imply more
flattened distributions of receptors. The cost function
F (m) = mα, and its associated optimal distribution
P ∗r ∝ Q1/(1+α)r , help illustrate this point. Such cost
functions can arise when both m(t) and F (t) increase
exponentially as a function of time, but with different
exponents (see App. C). When α is large, the cost of
non recognition increases very quickly with time, calling
for an urgent response. Consequently the optimal im-
mune system tends to cover the space uniformly to get
all potential threats, even the unlikely ones, under con-
trol. Conversely, when α is low, the harm caused by
pathogens does not explode with time, meaning that the
system can afford to recognize the rarer pathogens late,
and focus its resources on the common ones.
In some situations, there may be little or even no dif-
ference between a late response, or no response at all,
because the total harm caused by an infection stabi-
lizes. For example, consider the cost F (m) = 1 − e−βm
which saturates at large effective times. In this case, the
optimal solution (Table I) relates receptor and antigen
through a square root as for linear cost, but with a cut-
off at low probabilities. This cut-off occurs because there
is little benefit to having receptors recognizing rare anti-
gens, whose recognition is likely to happen late, when
differences in recognition times do not matter anymore.
F (m) P ∗r A(N˜a)
mα C Q
1
1+α
r C
′(Nst/N˜a)1+α
lnm CQr C
′(Nst/N˜a)
1− exp (−βm) max{C√Qr − β, 0} C′/(β + N˜a/Nst)2
Θ(m−m0) max{ln (Qr) /m0 − C, 0} C′ exp(−m0N˜a/Nst)
TABLE I: The cost function F (m) measures the harm caused
to an organism by the time that immune receptors have had m
encounters with a pathogen. The optimal receptor distribution
P ∗ is determined by minimizing this cost, given a pathogen dis-
tribution Q, and a cross-reactivity function fr,a specifying the
probability that receptor r binds to antigen a. The second col-
umn gives the form of P ∗ over scales larger than the cross-
reactivity. The optimal P ∗ can be reached as a steady-state
resulting from competitive binding between receptors and anti-
gens (see last section of Results) quantified by an “availability
function” A. N˜a =
∑
r Nr fr,a represents the coverage of anti-
gen a by the repertoire, Nst =
∑
r Nr is the total steady state
population and C,C′, β, andm0 are positive constants.
Real harm may occur only when the effective time m
4crosses a threshold. This situation can be modeled by
taking F (m) = Θ(m − m0) = 0 for m < m0, and 1
otherwise. In this case the receptor distribution should
be organized to maximize the chance of detection before
m0. The optimal repertoire for this cost (Table I) has no
receptors for the least frequent pathogens (cutoff at low
probabilities) and a drastically flattened receptor distri-
bution (logarithm of the pathogen distribution).
Is there a cost function for which the receptor distribu-
tion is not flattened relative to the pathogen distribution?
This occurs in a special case where cost increases very
slowly (logarithmically) with effective time. However, in
general, cost is minimized by a receptor distribution that
is flattened relative to the pathogen distribution.
B. Cross-reactivity dramatically reduces diversity
in the optimal repertoire
By allowing receptors to bind to a variety of antigens,
cross-reactivity should permit the immune system to re-
duce the number of receptor types required to cover the
whole range of possible threats. We will show that given
sufficient cross-reactivity, the optimal immune repertoire
concentrates all its resources on a few receptors, which
together tile antigenic space.
Following Perelson and Oster [12], we think of recep-
tors and antigens as points in a common high dimensional
shape space, whose coordinates are associated to unspec-
ified physicochemical properties. For simplicity, assume
that cross-reactivity only depends on the relative position
of receptor and antigen in shape space fr,a = f(r − a),
where f is a decreasing function of the distance between
a and r. Short distances in shape space correspond to
a good fit between the two molecules, leading to strong
recognition, while large distances translate into weak in-
teractions and poor recognition.
In order to build intuition, we first consider an analyt-
ically solvable example (Fig. 2). We describe the space
of receptors and antigens by a single continuous number,
and assume a Gaussian antigen distribution with variance
σ2Q, and Gaussian cross-reactivity of width σ, which sets
the typical distance within which a receptor and antigen
interact. We derive the optimal receptor distributions an-
alytically for costs of the form F (m) = mα (App. D 3 b).
For narrow cross-reactivities (σ < σc = σQ
√
1 + α), the
optimal receptor distribution is Gaussian with variance
(1 + α)σ2Q − σ2 and the optimal cost is independent of
σ. For wide cross-reactivities (σ > σc), the receptors
are optimally of a single type with reactivity centered on
the pathogen distribution, while the optimal normalized
cost increases with σ since the receptor is unnecessar-
ily broadly reactive. These results arise from a tension
between two opposing tendencies. As in the non cross-
reactive case, the need to cover rare pathogens broadens
the optimal receptor distribution relative to the pathogen
distribution. But cross-reactivity has the opposite effect,
favoring more concentrated distributions.
FIG. 2: The optimal cost and receptor distributions for pro-
tecting against a one-dimensional Gaussian antigenic land-
scape Q(a) of variance σ2Q, as a function of the cross-reactivity
width σ. As σ increases, the optimal distribution P ∗(r) be-
comes narrower and narrower (left and middle insets), until it
concentrates entirely onto a single point, for σ ≥ √2σQ (right
inset). The minimal cost (multiplied by σ for a comparison at
constant recognition capability) is constant below the transi-
tion point, but increases with σ past it. The cross-reactivity
function, which quantifies the affinity between receptor r and
antigen a as a function of their distance in shape space, has a
Gaussian form: f(r − a) = exp[−(r − a)2/2σ2], and the cost
function is linear in the effective recognition time, F (m) = m.
Does cross-reactivity generically drive the optimal re-
ceptor distribution to cluster into peaks? We investi-
gated this question numerically. For concreteness, we
consider a linear cost F (m) = m, and random pathogen
environments in one or two dimensions constructed by
drawing each Qa from a log-normal distribution char-
acterized by a coefficient of variation κ. For numerical
purposes, the shape space is taken to be bounded and
discretized, and we use accelerated gradient projection
optimization (App. E). We find that the optimal reper-
toire P ∗ is strongly peaked on a discrete forest of recep-
tors (Fig. 3A,B). The width of these peaks decreases as
numerical precision is increased, suggesting that the true
optimum consists of a weighted sum of Dirac delta func-
tions, i.e. distinct, discretely spaced receptors in different
amounts (see Fig. 6). By inspection, the peaks are spaced
evenly, at roughly the cross-reactivity scale σ, suggesting
that P ∗ is smooth when viewed at scales larger than σ.
Confirming this, P˜ ∗ (i.e. the coverage of the antigenic
space by the receptors) smoothly tracks the variations in
the antigen distribution Qa at a broad scale (Fig. 3A).
When viewed coarsely in this way, cross-reactivity is ir-
relevant and P ∗ tends to the solutions of Table I.
How can we quantitatively understand such distribu-
tions which are fragmentary in detail, but show organi-
zation when viewed coarsely (Fig. 3B)? A useful tech-
nique, borrowed from condensed matter physics, is to
measure the radial distribution function [13]: g(R) =
〈P (r)P (r′)〉|r−r′|=R, where |r − r′| is the distance be-
tween points r and r′. Fig. 3C presents g(R) for P ∗ in
two dimensions. The initial drop at small r indicates that
peaks in P ∗ are rarely close – i.e., peaks in the optimal
5FIG. 3: Cross-reactivity plays an important role in shaping
the optimal repertoire, often leading to highly peaked reper-
toires. (A)-(B): The optimal receptor distribution P ∗r for (A)
one- and (B) two-dimensional random environments. Despite
being peaked, the optimal distribution of receptors covers the
antigenic space fairly uniformly, as shown by its coverage by
the receptors, P˜ ∗a =
∑
r fr,aP
∗
r , shown in the one-dimensional
case (A). The cross-reactivity and cost functions are the same
as in Fig. 2. The antigenic landscape Qa is generated ran-
domly from a log-normal distribution with coefficient of vari-
ation κ = 1. (C)-(D): Structural analysis of the tiling pattern
formed by the peaks of the optimal receptor distribution P ∗r ,
in two dimensions. (C) The radial distribution function of
P ∗r shows an exclusion zone around each peak, followed by
oscillations characteristic of a local tiling pattern. (D) Nor-
malized power spectral density S(q) of P ∗r for different values
of the parameter κ quantifying the heterogeneity of the anti-
genic landscape. The high suppression of fluctuations at large
scales (small q) indicates that the pattern has very little fluc-
tuations in the number of receptors used to cover large surface
areas.
repertoire tend to repel each other. This exclusion, which
operates over the range of strong cross-reactivity, is a sen-
sible way to distribute resources, as it limits redundant
protection against the same pathogens. The damped os-
cillation of the peaks of g(R) confirm that the receptors
in P ∗ are organized into a disordered tiling pattern. A
similar radial distribution function is seen in high den-
sity random packings of hard spheres where the spheres
must cover as much space as possible but exclude each
other. In both cases, the tiling ensures uniform coverage
of space at large scales.
To quantify the regularity of the tiling, we calculate
the normalized power spectral density of the 2D pat-
tern: S(q) =
∑
r,r′ PrPr′e
iq(r−r′)/
∑
r P
2
r , where q is a
wave vector. Large (small) |q| correspond to short (long)
distances in antigen shape space. When Pr is made
of Dirac delta peaks of uniform heights, S(q) coincides
with the structure factor familiar in physics, and satis-
fies S(q → ∞) = 1. Fig. 3D shows S(q) averaged over
FIG. 4: Two individuals in the same environmentQa that see
it with slightly different noises have similar coverages of the
antigenic space, but achieve it with different receptors. This
results in largely non-overlapping repertoires. Shown are the
overlaps (normalized to be between 0 and 1) between the ex-
perienced pathogen distributions Qa, the resulting optimal re-
ceptor distributions P ∗r , and the corresponding coverages P˜a,
as a function of the noise  with which individuals perceive the
environment. The right plots show an example of antigenic
environments and optimal receptor distributions for  = 0.2.
We calculated the optimal receptor distributions for two in-
dividuals 1 and 2 experiencing respective environments Qez1
and Qez2 , where Q is a random environment with fluctuations
on scales larger than the cross-reactivity σ (power spectrum
∝ 1/(1 + (10qσ)2)) normalized so that its coefficient of vari-
ation is 0.5, and z1, z2 are Gaussian noises of mean zero and
variance 2. The choice of cost and cross-reactivity functions
are the same as in Fig. 2.
many realizations of the antigen landscape, and over all
directions of q so that it only depends on its modulus
|q|. S(q) approaches 1 for large q, showing that the pre-
cise local positions of the peaks are random. (The small
departure from 1 is attributable to numerical discretiza-
tion.) S(q) is very low for small q, indicating that the
number of receptors contained in any given large area of
the shape space is very reproducible, providing uniform
coverage. This phenomenon of small scale randomness
with large-scale regularity is called hyperuniformity [14],
and arises in jammed packings [15, 16] as evidence of the
incompressibility of the material. For our optimal reper-
toires small scale fluctuations (large q) get smoothed out
by cross-reactivity and can be tolerated, while at large
scales the fluctuations track variations in the antigenic
landscape to provide smooth coverage (see Fig. 7).
To test the generality of our findings we tested other
choices of cross-reactivity functions. We found that the
optimal repertoire remains strongly peaked, although the
position, number and strength of the peaks do change
(Fig. 8). Next we considered distributions of antigens
with correlations across shape space (reflecting e.g. phy-
logenic correlations between pathogens). Again we find
peaked optimal receptor distributions (Fig. 9), similar to
those for uncorrelated antigen landscapes. For computa-
6tional reasons, we restricted our analysis to two dimen-
sional pathogen landscapes, but the analogy with ran-
dom packing problems that we discussed above allows us
to expect that all of these results will hold generally in
higher dimensions.
In summary, the optimal immune repertoire looks ran-
dom at scales smaller than the cross-reactivity, but has
the structure of a disordered tiling at larger scales so
that, after accounting for cross-reactivity, the repertoire
smoothly covers the pathogen landscape. These findings
have an important consequence for different individuals
exposed to the same pathogenic environment. Each in-
dividual will experience a slightly different spectrum of
antigens because of the statistics of encounters and other
sources of variability. These slightly different experiences
of the same world lead to optimal repertoires with a strik-
ing property – the receptor distributions are largely dif-
ferent, even though their coverage of the pathogen land-
scape is similar after including cross-reactivity (Fig. 4).
This finding can be compared with surveys of “public”
repertoires of immune receptors [2, 17].
C. The optimal repertoire can be reached through
competition for antigens
The results presented so far have established how
repertoires should be structured to provide optimal pro-
tection. Given the complex interdependences between
receptors arising from local and global trade-offs, one
might think that the globally optimal solution could only
be reached via some biologically implausible centralized
mechanism distributing resources system-wide. In fact,
we will show that the optimal repertoire can be reached
through self-organization, via competitive evolution of
receptor populations under antigen stimulation.
We consider a model that is similar to that introduced
by de Boer, Perelson and collaborators for competitive
dynamics of B and T cells [18, 19]. Its main assumptions
are that division of receptor-expressing lymphocytes is
driven by antigen stimulation, and that receptors com-
pete for the limited supply of antigens. The number Nr
of receptors of a given type r evolves according to:
dNr
dt
= Nr
[∑
a
QaA
(∑
r
Nrfr,a
)
fr,a − d
]
. (3)
Receptors proliferate upon successful recognition by anti-
gens (first term of the equation) and die with a con-
stant rate d (second term of the equation). The growth
rate of a receptor type is proportional to the number of
antigens that it detects. In the absence of competition,
this amount is simply
∑
aQafr,a, but the antigen a will
also bind other receptors, reducing its availability for re-
ceptor r. The coverage of antigen a by the repertoire,
N˜a =
∑
rNrfr,a, quantifies the breadth of the receptor
pool competing to bind with a. The availability of anti-
gen a for binding is assumed to be a decreasing function
A(N˜a) of its coverage. The stimulation of r by a is thus
modified to:
∑
aQaA(N˜a)fr,a as in Eq. 3. For a given
pathogenic environment, the total steady-state receptor
population size N will be set by the death rate d, which
counter-balances growth at steady state.
The stable fixed points of the dynamics (3) realize the
optimal repertoires of the previous sections when the
availability function A is matched to the cost function
F (m) through the relation
A
(
N˜a
)
= −c′F¯ ′
(
N˜a/Nst
)
, (4)
where Nst is the total number of receptors
∑
rNr at
steady state. Table I shows A(N˜) for several cost func-
tions. To understand this result, first note that when
binding is not cross-reactive the dynamical equations
for each receptor are independent, and read: dNr/dt =
Nr(QrA(Nr)−d). The availability function now depends
only on Nr, meaning that receptors only compete with
their own kind — they occupy their own antigenic niche.
The steady state size of clone r is thus set by the carry-
ing capacity of that niche, Nr = A
(−1)(d/Qr), or zero if
that capacity is negative. With the availability given by
Eq. 4, this reproduces the optimal repertoire (Eq. 2). A
similar argument holds when receptor binding is cross-
reactive (App. F). Cross-reactivity leads to competition
amongst receptor types, effectively enforcing an exclusion
between similar receptors. This phenomenon, known in
ecology as competitive exclusion, is important for lym-
phocyte dynamics [18], and provides the mechanism by
which our dynamical model reproduces the discrete clus-
tering found in the optimal receptor distribution.
To check that the dynamics do converge to the op-
timum, we simulated Eq. 3 numerically for a random
antigenic environment in two dimensions, with A(N˜) =
1/(1 + N˜/N0)
2. Fig. 5 shows the dynamics of the re-
ceptor distribution Pr(t) = Nr(t)/
∑
r′ Nr′(t), as well as
its cost relative to the optimal solution, as a function
of time. Starting from a uniform initial distribution of
receptors, the repertoire reorganizes into localized peaks
that become increasingly prominent and well-separated
with time, with almost no receptors in between. Starting
from a random initial condition leads to the same steady
state (Fig. 10). The cost converges towards the global
minimum, indicating that the steady-state solution is in-
deed optimal.
In summary, competitive dynamics can allow the im-
mune repertoire to self-organize into a state that confers
high protection against infections. In the special case
when the availability A is scale invariant, the expected
cost is a Lyapunov function of the dynamics (App. G).
In this case, we can prove analytically that regardless of
the initial condition the cost will steadily decrease until
the optimum is reached.
7FIG. 5: The immune repertoire can self-organize to a state
that minimizes cost and provides protection against infec-
tions via competitive evolution of receptor populations stim-
ulated by antigens. Numerical solution of the population dy-
namics (Eq. 3) shows how competition causes a uniform ini-
tial receptor distribution to fragment into a highly peaked
pattern (insets representing Pr(t) = Nr(t)/
∑
r′ Nr′(t)).
The top-right inset represents the antigenic environment
Qa driving the dynamics (generated as in Fig. 3B). De-
parture from optimality, as measured by the relative cost
gap [〈F 〉 (Pr(t)) − 〈F 〉 (P ∗r )]/ 〈F 〉 (P ∗r ), decreases with time
and eventually reaches zero. We use the availability func-
tion A(N˜) = 1/(1 + N˜/N0)
2 with N0 = 10
6, a death rate
d = 0.01 and a cost function F (m) = 1−e−βm with β = 0.04.
The space size is 10σ. The initial condition is uniform with∑
r Nr(0) = 2.5 · 107.
III. DISCUSSION
We introduced a general framework for predicting the
optimal composition of the immune repertoire to mini-
mize the cost of infections contracted from a given dis-
tribution of antigens. This framework can be extended
in several ways to be more biologically faithful, e.g.
by accounting for receptor-dependent cross-reactivities,
antigen-dependent infection dynamics, and evolution of
the pathogenic landscape. Our predictions can be tested
in experiments that study how the environment influ-
ences the composition of immune repertoires, either via
high-throughput sequencing surveys of receptor popula-
tions [2, 20], or by sequencing receptors specific to given
antigens [21]. The comparison between theory and exper-
iment will provide insight into the functional constraints
of antigen recognition by the immune system.
There are many situations where living systems must
respond to very diverse and often very high dimensional
spaces of external influences using strictly limited re-
sources. To sense, internally represent, and then respond
to these influences, organisms often employ a large di-
versity of components, such as cell types or genes [22],
each sensitive to a small part of the space. For example,
the retina supports a diverse population of ganglion cell
types, each sensitive to a different visual feature, that
collectively represent the behaviorally salient aspects of
visual scenes [23, 24]. Likewise, the mammalian olfactory
system contains some ∼1000 distinct receptors that each
bind widely to odorants, and collectively cover olfactory
space [25]. In these cases, the limited repertoire of com-
ponent types provides a key constraint on information
processing. Faced with such constraints, living systems
must commit resources wisely, adapting to the structure
of the environment, and balancing breadth of coverage
against depth of resolution, in light of priorities, costs
and constraints [26]. We have shown that these elements
also shape the optimal form of the immune repertoire.
Our finding that cross-reactivity causes the optimal
repertoire to fragment is related to the concept of lim-
iting similarity due to competitive exclusion in ecolog-
ical settings [27–31]. In the latter context, empty re-
gions of phenotypic space result when competition is im-
portant on the scale at which resources vary [27], and
continuous coexistence of species only occurs in excep-
tional cases [30]. In general, niche-space heterogeneity
promotes species clustering [28, 31], recalling our find-
ing that any heterogeneous antigen distribution leads to
fragmentation of the optimal repertoire. The conceptual
connection between the immune repertoire and ecologi-
cal organization is even clearer in our dynamical model
where species compete for an array of resources (the anti-
gens), and grow in relation to their success in securing
resources.
Although this study relies on a simple abstraction of
the adaptive immune system, we expect that our frame-
work and results will extend to other distributed protec-
tion systems where diverse threats are addressed by an
array of specific responses. For example, the immune sys-
tem of bacteria, or CRISPR system [32], for which popu-
lation dynamics models have already been proposed [33],
could be studied within a similar framework to predict
the relative abundance of CRISPR spacers and corre-
sponding viruses in a co-evolving population of bacteria
and viruses.
Acknowledgements. The work was supported by
grant ERCStG n. 306312. VB was supported by the
Fondation Pierre-Gilles de Gennes, NSF grants PHY-
1058202 and EF-0928048. Portions of this work were
done at the Aspen Center for Physics, supported by NSF
grant PHY-1066293. AM was supported by a DAAD
Promos stipend.
Appendix A: Probability distribution of the time of
first recognition
In order to calculate the cost of not-recognizing an anti-
gen a, we need to find the distribution of times when a
successful encounter takes place. The probability of hav-
ing the first recognition of antigen a by receptor r in the
8time between t and t+ dt reads:
Ha(t)dt = λa(t)dt ·
∑
r
Prfr,a
× lim
N→∞
N∏
i=1
(
1− λa(ti) t
N
∑
r
Prfr,a
)
,
where the first term is the probability of having an en-
counter between t and t+dt, the second the probability of
this encounter being successful, and the third the prob-
ability of there not being any prior recognition events.
For the calculation of the last term we have decomposed
the time leading up to t into N intervals of length t/N .
Taking the N →∞ limit yields:
Ha(t) = λa(t)P˜ae
− ∫ t
0
dt′λa(t′)P˜a , (A1)
where we have used the short-hand notation P˜a =∑
r Prfr,a for the probability that a randomly chosen re-
ceptor recognizes antigen a.
Appendix B: Convexity of the expected cost
In this Appendix we show that the cost function 〈F 〉
is a convex function of its argument {Pr} (the receptor
distribution). We start by introducing an alternative ex-
pression of F¯a, obtained by integration by parts:
F¯a =
∫ ∞
0
dmF ′a(m)e
−mP˜a + F (0). (B1)
We calculate the derivatives of this average cost with
respect to P˜a:
dF¯a
dP˜a
= −
∫ ∞
0
dmmF ′a(m)e
−mP˜a (B2)
d2F¯a
dP˜ 2a
=
∫ ∞
0
dmm2F ′a(m)e
−mP˜a (B3)
Since by assumption F ′a(m) is positive, the second deriva-
tive of F¯a with respect to P˜a is positive. This estab-
lishes the convexity of P˜a as a function of P˜a. Since
〈F 〉 = ∑aQaF¯a (with Qa ≥ 0), it is a convex function
of {P˜a}. Therefore it is also a convex function of {Pr},
as {Pr} and {P˜a} are linearly related.
Appendix C: Biological motivation of power-law cost
functions
In the main text we have developed a general frame-
work for discussing the antigen-receptor recognition pro-
cess. To fully specify the model we need to choose an
effective cost function Fa(m) = Fa(ta(m)). In the main
text we derive optimal receptor distributions for a num-
ber of effective cost functions, including power-law func-
tions F (m) = mα. Here we sketch plausible scenarios
motivating that choice.
FIG. 6: Solving the optimization problem with a finer and
finer discretization step suggests that the peaks found in the
optimal receptor distributions converge to true Dirac delta
functions. Starting from a problem with a discretization
step of ∆ = 0.1σ, we construct coarse-grained versions of it
by downsampling the antigen distribution two and four fold,
yielding ∆ = 0.2 and 0.4 respectively. The resulting coarse-
grained optimization problems are then solved, and the op-
timal distributions P ∗r /∆ represented (after appropriate nor-
malization by the step size). The random antigen distribution
is log-normal with coefficient of variation κ = 0.25.
Consider an organism being infected with a antigen
a. As long as there is no immune reaction, the antigens
divide inside its host and thus increase its population
size. If the initial population size is small it is reasonable
to assume exponential growth.
The more antigens there are at the time of the im-
mune reaction the more damage they can potentially do.
Likewise, the more antigens, the higher the rate of en-
counters. These two quantities are also expected to grow
exponetially in time:
Fa(t) = Fa(0)e
νat, (C1)
λa(t) = λa(0)e
ν′at (C2)
The two exponents may be different in general, because
the number of pathogenic agents that cause the harm
may grow differently than the number of antigens that
can be recognized by the immune system. This difference
could for example come stem from the fact that both the
pathogen’s antigenic exposure and its virulence are coop-
erative effects, and thus scale as a power of the number of
invading individuals. Using ma(t) = λa(0)(e
ν′at − 1)/ν′a,
and eliminating time t ≈ ln[ma/λa(0)]/ν′a (for t large
compared to 1/ν′a), we rewrite the effective cost function
in terms of the number of encounters:
Fa(m) = Fa(0)
(
m
λa(0)
) νa
ν′a ∝ mα, (C3)
with α = νa/ν
′
a.
9FIG. 7: Power spectral density normalized by the
squared antigenic environment heterogeneity index κ:
|∑r Preiqr|2/κ2. The data collapse for different κ shows that
the fluctuations at large scale are entirely attributable to those
of the antigenic environment, and scale with them. At these
large scales, the power spectrum of the receptor distribution
is approximately given by: exp[(qσ)2/2]/4. The exponential
term stems from the inverse of the Fourier transform of f (see
Eq. D21). Parameters are the same as in Fig. 3.
Appendix D: Analytical optimization
1. Optimality conditions
In the following we give optimality conditions for the
optimization problem defined in the main text, which
will be used for the following analytical determination of
optimal receptor distributions. These conditions, called
Karush-Kuhn-Tucker conditions [34], are derived from a
generalization of the method of Lagrange multipliers to
inequality as well as equality constraints.
The Lagrangian for the optimization problem is
L(P, λ, ν) = 〈F 〉 (P ) +λ
(∑
r
Pr − 1
)
−
∑
r
νrPr, (D1)
with
〈F 〉 =
∑
a
QaF¯a. (D2)
λ is a Lagrange multiplier enforcing the normalization
constraint and νr are Lagrange multipliers enforcing the
non-negativity constraint. The optimal P ∗ is an ex-
tremum of this Lagrangian. Thereore the stationarity
conditions:
∂ 〈F 〉
∂Pr
∣∣∣∣
P∗
+ λ∗ − ν∗r = 0, (D3)
with
∂ 〈F 〉
∂Pr
=
∑
a
QaF¯
′
a(P˜a)fr,a, (D4)
must hold for some value of λ∗ and ν∗r that enforce the
constraints. The inequality constraint Pr ≥ 0 further
requires that:
ν∗r ≥ 0 (D5)
ν∗rP
∗
r = 0, (D6)
where the second is known as the complementary slack-
ness condition. It requires the Lagrange multipliers as-
sociated with the non-negativity to be zero unless the
constraint is active, i.e. unless the corresponding recep-
tor probability is zero.
The three conditions may be reformulated as:
∂ 〈F 〉
∂Pr
∣∣∣∣
P∗
+ λ∗ ≥ 0 (D7)(
∂ 〈F 〉
∂Pr
∣∣∣∣
P∗
+ λ∗
)
Pr = 0 (D8)
For all receptors that are present in the optimal reper-
toire (P ∗r > 0) these conditions imply
∂ 〈F 〉
∂Pr
∣∣∣∣
P∗
= −λ∗. (D9)
If a receptor is not present in the optimal repertoire
(P ∗r = 0) then the less stringent condition holds:
∂ 〈F 〉
∂Pr
∣∣∣∣
P∗
≥ −λ∗. (D10)
We note here that ∂ 〈F 〉/∂Pr ≤ 0 (because more recep-
tors always yield a lower cost), so that λ∗ ≥ 0.
These two conditions can be explained as follows: if
a repertoire is optimal, all changes allowed by the con-
straints will lead to a higher cost, i.e. moving receptors
from one type to another will not yield an improvement.
All partial derivatives of the cost with respect to the re-
ceptor probabilities should thus be equal to the same
value (Eq. D9). If there are already no receptors of a
certain type, i.e. Pr = 0, we get a less stringent condi-
tion. We can no longer remove receptors away from this
type r, but only add some to it, at the expense of other
receptor types. The increase in cost due to the depletion
of these other types should be higher than the gain of
moving them to type r. The partial derivatives of the
cost with respect to the receptors that are not present
in the repertoire must thus be larger than the partial
derivatives of the present receptors, which are given by
−λ∗ (Eq. D10).
2. Solution for uniquely specific receptors
We now solve Eqs. D9 and D10 for a repertoire of
uniquely specific receptors (no cross-reactivity). Eq. D4
becomes
∂ 〈F 〉
∂Pr
= QrF¯
′
r (Pr) , (D11)
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FIG. 8: Influence of the choice of the cross-reactivity kernel f(a − r) on the optimization problem. Regardless of the kernel
choice the optimal repertoire is peaked for non-uniform antigen distributions. The details of distribution depend on the cross-
reactivity kernel. (A): Kernel functions used to describe cross-reactivity. We use the family of kernel functions defined by
f(r − a) = exp[−(|r − a|/η)γ ]. By changing the parameter γ we can go from an exponential (γ = 1) via a Gaussian γ = 2 to a
top-hat kernel (γ →∞). Up to γ = 2 all such kernels have positive Fourier transforms, whereas for γ > 2 the Fourier transforms
also take negative values [30]. (B): Examples of optimal receptor distributions in two dimensions, for antigenic environments
generated as in Fig. 3B (with coefficient of variation κ = 0.25). (C) Radial distribution function of the optimal distribution.
(D) Structure factor of the optimal distribution. The results in both (C) and (D) are averaged over 10 independent runs. A
linear effective cost function F (m) = m is assumed throughout. The random antigen distribution is log-normal with coefficient
of variation κ = 0.25.
where we have used the fact that in the absence of cross-
reactivity P˜a = Pa. If all optimal receptor probabilities
are positive then we can insert this relationship into Eq.
D9 to obtain
QrF¯
′
r (P
∗
r ) = −λ∗. (D12)
and thus:
P ∗r = hr (−λ∗/Qr) , (D13)
where hr = F¯
′(−1)
r denotes the inverse function of F¯ ′r.
Since that function F¯ ′r is always negative, hr must take
a negative argument.
For some cost functions, solving this equation may
yield some negative receptor probabilities. In these cases
some of the non-negativity constraints need to be active.
Setting Pr = 0 when Eq. D13 is negative yields the cor-
rect optimal distribution under the non-negativity con-
straint. We verify that for these r, Eq. D10 is satisfied
by Pr = 0, because:
QrF¯
′
r (Pr = 0) ≥ QrF¯ ′r[hr (−λ∗/Qr)] = −λ∗, (D14)
where we have used the fact that F¯ ′r is a increasing func-
tion of its argument (due to the positivity of its deriva-
tive, cf. Eq. B3), and hr (−λ∗/Qr) ≤ 0
In summary, the solution to the optimization problem
is
P ∗r = max{hr (−λ∗/Qr) , 0}, (D15)
where the value of λ∗ is fixed by the normalization con-
dition
∑
r Pr = 1.
In Tab. II we give the explicit expressions of F¯a and
ha, for the particular choices of the cost function F (m)
considered in the main text.
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FIG. 9: Adding correlations to the antigen distribution does
not change the peakedness of optimal receptor distributions.
The result of the optimization is shown for a random antigen
landscape with correlations. The antigen distribution is gen-
erated by Fourier filtering. First we generate an uncorrelated,
normally distributed random series. This series is then filtered
to obtain a power spectrum ∝ 1/(1 + (10qσ)2). Finally, the
filtered series is exponentiated to ensure the non-negativity of
the generated values.
FIG. 10: Numerical solution of the population dynamics de-
scribed in the main text as a function of time. The same
calculation as in Fig. 5, but using a random initial condition
(log-normal with coefficient of variation 1) shows the same
convergence to the optimal receptor distribution.
F (m) F¯ (P˜a) h(x)
mα Γ(1 + α)/P˜αa (−x/(αΓ(1 + α)))
1
1+α
lnm γ − ln P˜a −1/x
1− exp (−βm) β/
(
β + P˜a
) √−β/x− β
Θ(m−m0) exp
(
−m0P˜a
)
− ln(−x/m0)/m0
TABLE II: Intermediate results in the derivation of the op-
timal solution. The first column shows several choices of the
effective cost function, F (m). For these cost functions the
second column shows the average cost of a pathogenic attack,
F¯ (P˜a), and the third column shows the inverse of its deriva-
tive, h =
(
F¯ ′
)−1
. Γ is the Gamma function, γ is Euler’s
constant, β and m0 are positive constants.
3. Solution for cross-reactive receptors
The previous results can be generalized to cross-
reactive receptors in a continuous space, using Fourier
transforms. This generalization will lead up to the re-
sults presented in the Cross-reactivity dramatically limits
optimal repertoire diversity section of the main text, and
notably the Gaussian case discussed therein.
a. Deconvoluting the optimality conditions in Fourier space
We consider a continuous receptor-antigen space and
we assume a translation invariant cross-reactivity func-
tion fr,a = f(r − a). We write the optimality condition
Eq. D9∫
dp Q(a)F¯ ′
[
P˜ ∗(a)
]
f(r − a) = −λ∗, (D16)
where in continous space the coverage is defined as:
P˜ (a) =
∫
dr P (r)f(r − a). (D17)
We notice that both expressions involve integrals, which
are convolutions with the cross-reactivity kernel. Since
the convolution of a constant is also a constant, a solution
of
Q(a)F¯ ′
(
P˜ ∗(a)
)
= −λ′, with λ′ > 0, (D18)
is also a solution of Eq. D16. As in the case of uniquely
specific receptors, we can solve this equation for P˜ ∗(a):
P˜ ∗(a) = h [−λ′/Q(a)] , (D19)
where h = F¯ ′(−1) as in D13. If there was no cross-
reactivity, there would be no difference between P and
P˜ , and we would be done. Here we need to perform a de-
convolution to obtain the optimal receptor distribution
P from the optimal coverage P˜ . We do so in Fourier
space, where the convolution turns into a product. De-
convolution is therefore much simpler in Fourier space as
it corresponds to a division
F [P˜ ] = F [P ]F [f ] ⇔ F [P ] = F [P˜ ]/F [f ], (D20)
where we have defined the Fourier transform of a func-
tion g(x) as F [g](k) = ∫∞−∞ dxg(x)eikx. To calculate
the optimal receptor distribution we insert Eq. D19
into Eq. D20 and perform an inverse Fourier transform
F−1[g˜](x) = (1/2pi) ∫∞−∞ dkg˜(k)e−ikx to obtain
P ∗ = F−1 [F [h (−λ′/Q)]/F [f ]] . (D21)
This result is only valid as long as the above quantity is
positive and normalizable, as we shall see below.
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b. The Gaussian case
In this section we apply the general results of the previ-
ous section to a concrete example. In order to find the op-
timal receptor distribution analytically we use Eq. D21,
we assume the antigen distribution and cross-reactivity
function are Gaussian
Q(a) =
1√
2piσ2Q
exp
(−a2/2σ2Q) , (D22)
f(r − a) = exp [−(r − a)2/2σ2] , (D23)
and we take
F (m) = mα. (D24)
Inserting h from Tab. II into Eq. D21 allows us to write
P ∗ ∝ F−1
[
F [Q 11+α ]/F [f ]
]
(D25)
as an equivalent equation determining the optimal reper-
toire. We can calculate the modified antigen distribution
as
Q(a)
1
1+α ∝ exp
(
− a
2
2(1 + α)σ2Q
)
. (D26)
The Fourier transform of a Gaussian function of variance
σ2 is a Gaussian function of variance 1/σ2 [35]. Therefore
we have
F [Q 11+α ](q) ∝ exp [−(1 + α)σ2Qq2/2] , (D27)
F [f ](q) ∝ exp [−σ2a2/2] , (D28)
from which
F [Q 11+α ]/F [f ] ∝ exp{−[(1 + α)σ2Q − σ2]q2/2} (D29)
follows. Taking the inverse Fourier transform and nor-
malizing, we obtain
P ∗(r) =
1√
2pi[(1 + α)σ2Q − σ2]
exp
(
− r
2
2[(1 + α)σ2Q − σ2]
)
.
(D30)
Normalization is only possible for σ < σQ
√
1 + α ≡ σc.
In the limit σ → σc the Gaussian converges to a Dirac
delta function. Intuition suggests that a Dirac delta func-
tion centered on the peak position should remain optimal
for further increases in σ. To prove this assertion we note
that a Dirac delta function is zero everywhere, except in
one point. Since all but one receptor probabilities are at
the boundary defined by the non-negativity constraints,
we only need to check Eq. D10. We compute the left-
hand side of Eq. D16 as a function of r∫
dp Q(a)F¯ ′[P˜ ∗(a)]f(r − a)
∝ − exp
{
−r2[σ2 − (1 + α)σ2Q]
2σ2(σ2 − ασ2Q)
}
,
(D31)
and note that it has a minimum for r = 0. This shows
that the partial derivatives of the expected cost at r 6= 0
are greater than at r = 0, implying that Eq. D10 holds.
The cost of the optimal repertoires as a function of the
cross-reactivity width σ is given by
〈F 〉 (P ∗) =
(σQ
σ
)α{(1 + α) 1+α2 if σ < σc,
(σ/σQ)
α√
1−α(σQ/σ)2
otherwise.
(D32)
Both expressions give the same cost at the transition
σ = σc. After multiplying by (σ/σQ)
α to compare at
constant recognition capability
∫
f =
√
2piσ, this expres-
sion is constant for σ < σc, and grows for σ > σc.
c. General argument for peakedness
A simple argument can help understand why cross-
reactivity generically leads to peaked optimal solutions.
The convolution with a kernel is a smoothening opera-
tion, represented by a low-pass filter in the Fourier do-
main. The optimal solution in the absence of the non-
negativity constraints requires that P˜a = h(Qa). As P˜a is
the low-passed filtered version of Pr, the high-frequency
components of h(Qa) will be magnified by the deconvolu-
tion. These high-frequency wiggles can lead to negative
values of F−1[h(Qa)], which are not allowed, leading to
set many values of P (r) to zero. This effects results in a
peaked solution. Because the size of the cross-reactivity
kernel is inversely proportional to the cutoff frequency in
the Fourier domain, we expect the spacing of the peaks
to be related to the size of the cross-reactivity kernel.
Appendix E: Numerical optimization
We numerically minimize the cost function subject to
the normalization and non-negativity constraints by us-
ing a fast projected gradient algorithm. In the following
we provide details on this numerical algorithm. To fa-
cilitate notations let us define the function to minimize
as g(x), where x is a vector in a Euclidean space, and
the convex set C defined by the constraints. In these
notations the problem we want to solve can be stated as
min
x∈C
g(x). (E1)
Given an arbitrary starting point x0 ∈ C the algorithm
performs the following iterative procedure:
yk+1 = xk + ωk
(
xk − xk−1) , (E2)
xk+1 = P (yk+1 − sk∇g (yk+1)) , (E3)
where ∇ denotes the gradient. Here P denotes a projec-
tion onto C, ωk is an extrapolation step size and sk is
the step size taken in the direction of the gradient. The
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extrapolation step size has to be chosen carefully to en-
sure the faster convergence of this method with respect
to an ordinary gradient method. Following [36] we use
ωk =
k
k + 3
. (E4)
The step size s is determined by backtracking [37]: we
iteratively decrease s by multiplication by β < 1 until
g(z) ≤ g(yk) + (x− y) · ∇g(yk) + 12s (z − y)2, where x · y
denotes the inner dot product between x and y, and z =
P(yk − s∇g(yk)). In practice we determine s in this way
at the first step of the optimization and then keep it fixed
based on this initial estimate.
The projection of a point onto a convex set is defined
by the following quadratic programming problem:
P(y) = argmin
x∈C
1
2
(x− y)2. (E5)
If the convex set is a simplex as is the case for our prob-
lem, there fortunately exist efficient algorithms for solv-
ing this problem. We use the algorithm described in [38].
To stop the iteration one needs to define a suitable
stopping criteria. As the problem is convex we can es-
tablish a lower bound for the cost by solving a linear
programming problem as follows:
glb = g(x
k) + min
x∈C
[
(x− xk) · ∇g(xk)] ≤ g(x∗). (E6)
The linear programming problem x¯k =
argminx∈C ∇g(xk)T (x − xk) is solved explicitly [39]
by
x¯k = ei∗ , i
∗ = argmin
i
(∇g(xk))i, (E7)
where ei denotes the ith unit vector. We can use this
lower bound to define a stopping criterion for the numer-
ical optimization
g(xk)− glb
glb
< . (E8)
For all reported numerical results we have chosen  =
10−8.
The discretization steps used in the figures are listed
below:
Step Figure
0.25σ 5, 10
0.1σ 3, 7, 8, 9
0.05σ 4
Appendix F: Stable fixed point of population
dynamics minimizes corresponding cost function
In this section we show that the stable fixed point {N∗r }
of the population dynamics:
dNr
dt
= Nr
[∑
a
QaA
(∑
r
Nrfr,a
)
fr,a − d
]
(F1)
gives a probability distribution Pr = Nr/Ntot (with
Ntot =
∑
rNr) that minimizes the cost 〈F 〉. For this
correspondence to be exact, the availability function of
the dynamics and the effective cost function of the opti-
mization must be related by:
A(N˜a) = −c′F¯ ′(N˜a/Nst), (F2)
where N˜a =
∑
Nrfr,a, and Nst is the total number of
receptors Ntot at the fixed point.
A fixed point is characterized by dNr/dt = 0. If Nr >
0, this translates into∑
a
QaA
(∑
r
Nrfr,a
)
fr,a − d = 0. (F3)
Using the correspondence between availability and cost
function given by Eq. F2 we rewrite this condition as∑
a
QaF¯
′
(
P˜a
)
fr,a = −c′d, (F4)
which is equivalent to the optimality condition Eq. D9,
with the identification λ∗ = c′d.
For Nr = 0 we need to work a bit harder to show
that the optimality condition at the boundary Eq. D10
is satisfied. Here the key assumption establishing the
minimization of the cost function is the stability of the
fixed point. A fixed point is stable if the real parts of the
Jacobian’s eigenvalues are all negative. The Jacobian
reads:
Jr,r′ =δr,r′
(∑
a
QaA
(∑
r′
Nr′fr′,a
)
fr,a − d
)
+Nr
∑
a
QaA
′
(∑
r′
Nr′fr′,a
)
fr,afr′,a.
(F5)
We remark that for Nr = 0 the r
th row of the Jacobian is
non-zero only on the diagonal. That value on the diago-
nal is an eigenvalue of the Jacobian and must be negative:
∑
a
QaA
(∑
r′
Nr′fr′,a
)
fr,a − d < 0, (F6)
Again we replace A (
∑
rNrfr,a) by −F¯ ′a
(
P˜a
)
according
to Eq. F2 to obtain∑
a
QaF¯
′
(
P˜a
)
fr,a > −c′d, (F7)
which is equivalent to the optimality condition at the
boundary Eq. D10, provided that λ∗ = c′d.
Appendix G: Cost function as a Lyapunov function
of the dynamics
Here we show rigorously that, when the availability
function is scale invariant, as in the case for the simple
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cost function F (m) = mα, the dynamics must converge
towards a fixed point. This fixed point is unique and
corresponds to the optimal of the cost 〈F 〉, as we have
shown in the previous section.
A(x) is scale invariant if there exists a function v such
that A(γx) = v(γ)A(x). In this case we will see that
the changes of relative frequencies Pr in the repertoire
over time only depend on the total number of receptors
through a prefactor. Below we derive the equations gov-
erning this dynamics and will then prove that this dy-
namics is assured to converge to a stable fixed point. We
do so by showing that the dynamics admits the expected
cost 〈F 〉 as a Lyapunov function, i.e. a function that
continually decreases under the dynamics.
For ease of notation we rewrite Eq. F1 as:
dNr
dt
= Nr[pir(N)− d], (G1)
where N is a short-hand for {Nr}, and pir =∑
aQaA (
∑
rNrfr,a) fr,a is the growth rate of receptor
type r. The relative frequencies Pr = Nr/Ntot evolve
according to:
dPr
dt
=
1
Ntot
dNr
dt
− Nr
N2tot
dNtot
dt
(G2)
= Pr
[
pir(N)−
∑
r′
Pr′pir′(N)
]
. (G3)
If A is scale invariant, so is pir and pir(N) = pir(NtotP ) =
v(Ntot)pir(P ). Then the equations further simplify to
dPr
dt
= v(Ntot)Pr
[
pir(P )−
∑
r′
Pr′pir′(P )
]
, (G4)
= v(Ntot)Pr (pir − p¯i) , (G5)
where p¯i =
∑
r Prpir.
We can now write how the expected cost 〈F 〉 evolves
in time:
d 〈F 〉
dt
=
∑
r
∂ 〈F 〉
∂Pr
dPr
dt
(G6)
= v(Ntot)
∑
r
Pr
[∑
a
QaF¯
′
a(P˜a)fr,a
]
(pir − p¯i)
(G7)
= −v(Ntot)
c′
∑
r
Pr
[∑
a
QaA(NstP˜a)fr,a
]
(pir − p¯i)
(G8)
= −v(Ntot)v(Nst)
c′
∑
r
Prpir (pir − p¯i) (G9)
= −v(Ntot)v(Nst)
c′
∑
r
Pr (pir − p¯i)2 ≤ 0. (G10)
This proves that the cost always decreases with time,
i.e. is a Lyapunov function of the dynamics. Therefore
the dynamics will reach a stable fixed point at steady
state, which is garanteed to be the global minimum of
the expected cost 〈F 〉.
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